The difference between hydrochlorothiazide and irbesartan/hydrochlorothiazide

Nov 09, 2023 Source: Cainiu Health
Dr. Wang Xin
Introduction
In general, the differences between hydrochlorothiazide and irbesartan/hydrochlorothiazide include differences in composition, efficacy, indications, adverse reactions, and contraindications. The main component of hydrochlorothiazide is hydrochlorothiazide itself, whereas the main components of irbesartan/hydrochlorothiazide are irbesartan and hydrochlorothiazide. Medication should be used under the guidance of a doctor; patients must not use these drugs without medical supervision.

Generally, the differences between hydrochlorothiazide and irbesartan/hydrochlorothiazide include differences in composition, efficacy, indications, adverse reactions, and contraindications. Specific analysis is as follows:

1. Different Composition

The main component of hydrochlorothiazide is hydrochlorothiazide alone, whereas the main components of irbesartan/hydrochlorothiazide are irbesartan and hydrochlorothiazide.

2. Different Efficacy

Hydrochlorothiazide has diuretic and potassium-excreting effects, while irbesartan/hydrochlorothiazide provides diuresis, potassium excretion, and vasodilation.

3. Different Indications

Hydrochlorothiazide can be used to treat edematous conditions and hypertension, as well as nephrogenic diabetes insipidus and pituitary diabetes insipidus unresponsive to vasopressin. Irbesartan/hydrochlorothiazide is indicated for the treatment of essential hypertension, particularly in patients whose blood pressure cannot be adequately controlled with irbesartan or hydrochlorothiazide alone.

4. Different Adverse Reactions

Common adverse reactions after taking hydrochlorothiazide include electrolyte disturbances and hyperuricemia. Common adverse reactions after taking irbesartan/hydrochlorothiazide include hypotension, syncope, cough, and dyspnea.

5. Different Contraindications

Patients allergic to sulfonamide drugs should not use hydrochlorothiazide, while pregnant and breastfeeding women should avoid irbesartan/hydrochlorothiazide.

Medications should be used under the guidance of a physician. Patients must not self-medicate, to avoid potential adverse effects.